Evidence map›Paper›PMID 31903874›Full record

ReviewPathogens and global health2019

Circulation of

M I Cerezo-Cortés, J G Rodríguez-Castillo, R Hernández-Pando, M I Murcia

Abstract readReview
In one paragraph

Review in Pathogens and global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Draft whole-genome sequences of ancestral and modernMicrobiology resource announcements · 2026
    Article
  2. Article
  3. Article
  4. Molecular epidemiology ofJournal of clinical tuberculosis and other mycobacterial diseases · 2024
    Review
  5. Review
  6. Article
  7. Genomic comparison betweenFrontiers in veterinary science · 2024
    Article
  8. Article
  9. Review
  10. Heterogeneity of Mycobacterium tuberculosis Strains Circulating in Panama's Western Region.The American journal of tropical medicine and hygiene · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Close Related Drug-Resistance Beijing Isolates ofInternational journal of molecular sciences · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M I Cerezo-CortésGrupo MICOBAC-UN, Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0001-9629-1436
J G Rodríguez-CastilloGrupo MICOBAC-UN, Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0002-0732-6252
R Hernández-PandoExperimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition, México D.F., Mexico.
M I MurciaGrupo MICOBAC-UN, Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0002-4341-4786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lineage 2 (East Asian), which includes the Beijing genotype, is one of the most prevalent lineages of

Indexed as

GenotypeCaribbean RegionHumansLatin AmericaMycobacterium tuberculosisTuberculosisBeijingLatin AmericaMIRU-VNTRMolecular epidemiologyMycobacterium tuberculosisspoligotyping

Identifiers

PMID31903874
PMCPMC7006823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.